Genetic polymorphisms in the renin-angiotensin system: Relevance for susceptibility to cardiovascular disease

European Journal of Pharmacology

Volumn 410, Issue 2-3, 2000, Pages 289-302

  Wang, Ji Guang ^a   Staessen, Jan A ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Angiotensin II type 1 receptor; Angiotensin converting enzyme; Angiotensinogen; Cardiovascular disease; Gene polymorphism; Susceptibility

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ARTICLE; ATHEROSCLEROSIS; BELGIUM; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHINA; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0034723039     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00822-0     Document Type: Article

References (122)

1. Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Systematic overview of individual data from 100,000 patients in randomized trials
2. ACE gene polymorphism in cardiovascular disease: Meta-analysis of small and large studies in Whites
3. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: Association with early coronary disease
4. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction
5. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias
6. ACE in three tunicae of rat aorta: Expression in smooth muscle and effect of renovascular hypertension
7. Additive effects of losartan and enalapril on blood pressure and plasma active renin
8. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents
9. Synergistic effect of α-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion
10. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients
11. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals
12. Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients
13. Angiotensin converting enzyme genotype DD is a risk factor for coronary heart disease
14. Human renin-dependent hypertension in rats transgenic for human angiotensinogen
15. Angiotensin II type-1 receptor gene polymorphisms in human essential hypertension
16. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study
17. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
18. Tissue renin-angiotensin system: Sites of angiotensin formation
19. 1166 polymorphism. Relationships with blood pressure and cardiovascular structure
20. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans
21. Angiotensinogen in human essential hypertension
22. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese
23. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism
24. Genetic predisposition to diabetic nephropathy: Evidence for a role of the angiotensin I converting enzyme gene
25. Tissue renin-angiotensin system in myocardial hypertrophy and failure
26. Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms
27. Who's afraid of epistasis?
28. Angiotensin-I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM
29. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter
30. Structure of the human angiotensinogen gene
31. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension
32. Lack of association between renin-angiotensin system, gene polymorphisms, and wall thickness of the radial and carotid arteries
33. Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population
34. The renin-angiotensin system and long-term regulation of blood pressure
35. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries
36. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
37. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men
38. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population
39. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition
40. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy
41. Angiotensinogen genotype, sodium reduction, weight loss, and the prevention of hypertension. Trials of hypertension prevention, phase II
42. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro
43. Angiotensinogen polymorphism in Japanese patients with hypertrophic cardiomyopathy
44. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis
45. Essential hypertension and 5′ upsteam core promoter region of human angiotensinogen gene
46. Angiotensinogen gene polymorphism near transcription start site and blood pressure. Role of a T-to-C transition at intron I
47. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy
48. Molecular variants of the angiotensinogen gene and hypertension in a Japanese population
49. Molecular basis of human hypertension: Role of angiotensinogen
50. Haplotypes of angiotensinogen in essential hypertension
51. Polymorphism of angiotensin I converting enzyme gene in the older Chinese: Linked to ambulatory blood pressure levels and circadian blood pressure rhythm
52. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis
53. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives
54. Angiotensinogen gene and essential hypertension in the Japanese: Extensive association study and meta-analysis on six reported studies
55. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
56. T235 variant in angiotensinogen gene is also a risk factor for coronary heart disease
57. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls
58. Variation at angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure
59. Genetic control of blood pressure and the angiotensinogen locus
60. Association between the angiotensinogen 235T-variant and essential hypertension in whites. A systematic review and methodological appraisal
61. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: A meta-analysis
62. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
63. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind placebo-controlled trial of concomitant administration compared with individual components
64. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
65. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma
66. Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications
67. Contribution of genetic polymorphisms in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes
68. Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: Evidence for two quantitative-trait loci
69. Effect of angiotensinogen gene T235 variant on the development of diabetic complications in type II diabetes mellitus
70. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension in Japanese
71. Angiotensin-converting enzyme polymorphism and essential hypertension
72. Vascular angiotensin-converting enzyme expression regulates local angiotensin II
73. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in Japanese
74. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphism as a risk factor for coronary heart disease
75. 235-Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations
76. Angiotensin-converting enzyme gene polymorphism in haemodialysis patients
77. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study
78. A potent genetic risk factor for restenosis
79. Vascular renin angiotensin system in two kidney, one clip hypertensive rats
80. 1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy
81. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
82. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and essential hypertension: The ECTIM study
83. The deletion/insertion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension
84. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program
85. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy
86. Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease
87. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
88. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
89. Angiotensinogen gene in human hypertension: Lack of an association of the 235T allele among African Americans
90. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians
91. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme with myocardial infarction
92. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese
93. Association of ACE gene polymorphism and diabetic nephropathy?
94. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: Effects on coronary resistance, contractility and relaxation
95. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy
96. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis
97. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction
98. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition
99. A mouse view of hypertension
100. Genetic variability in the renin-angiotensin system: Prevalence of alleles and genotypes
101. The deletion/insertion polymorphism of the converting-enzyme and cardiovascular-renal risk
102. M235T angiotensinogen gene polymorphism and cardiovascular renal risk
103. Association between blood pressure, hypertension and polymorphisms of the aldosterone synthase and α-adducin genes in a Belgian population study
104. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension
105. Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarctions: The Ohasama Study
106. Molecular mechanism of transcriptional activation of angiotensonigen gene by proximal promoter
107. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients
108. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy
109. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels
110. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction
111. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction
112. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy
113. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progress in Japanese NIDDM patients
114. Chymase-dependent angiotensin II forming system in humans
115. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries
116. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis
117. Association of angiotensin II type I receptor gene polymorphism with esential hypertension
118. Lack of association of polymorphisms of the angiotensin converting enzyme and angiotensinogen genes with nonfamilial hypertrophic or dilated cardiomyopathy
119. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene
120. The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as candidate genes for microalbuminuria. A study in non-diabetic and non-insulin dependent diabetic subjects
121. Evaluation of three polymorphisms in the promotor region of the angiotensin II type I receptor gene
122. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene